Adstiladrin savings card: as little as $10 a prescription with commercial insurance

Adstiladrin is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How to pay the least

Given by your care team

Billed by the clinic

Adstiladrin is given by a doctor or nurse, not picked up at a pharmacy.

Ask your care team or your plan what you’d pay before your visit.

Compare every option

Brand nameAdstiladrin

Authorized genericnadofaragene firadenovec-vncg

Regular genericnadofaragene firadenovec-vncg

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldAsk the pharmacy

Same as Adstiladrin?

The original

–

Brand nameThe maker’s card

ADSTILADRIN Copay Program (Ferring Access Support)

Savings card from Ferring

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $10 a prescription

In the maker’s words

“Eligible, commercially insured patients may pay as little as $10 for each ADSTILADRIN prescription.”

From the maker’s offer on adstiladrinhcp.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Adstiladrin itself, from the same company, sold without the brand name, and usually for less. For now Adstiladrin is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Adstiladrin is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Non-muscle-invasive bladder cancer not helped by BCG

What the FDA label says

ADSTILADRIN is a non-replicating adenoviral vector-based gene therapy indicated for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumors.

Source: the FDA label for Adstiladrin (Ferring Pharmaceuticals Inc.), March 24, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to the clinic’s billing office.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/adstiladrin/